ClinicalTrials HQ

Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis

Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis

Recruiting · NCT04689152 · Registry updated 2026-09-21
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic CirrhosisChemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, substance-related disorderRecruitingPhase 32026-09-21NCT04689152

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Pharmicell Co., Ltd.5

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Eunpyeong St. Mary's HospitalSeoulSouth Korea4
Gangnam Severance HospitalSeoulSouth Korea30
Gangneung Asan HospitalGangneung-siSouth Korea2
Gangwon National University HospitalChuncheonSouth Korea4
Hallym Univ. Medical CenterChuncheonSouth Korea2
Korea University ANAM HospitalSeoulSouth Korea56
Korea University Ansan HospitalAnsanSouth Korea14
Seoul National University HospitalSeoulSouth Korea183
Seoul St. Mary's HospitalSeoulSouth Korea13
Severance HospitalSeoulSouth Korea62
Soonchunhyang University HospitalCheonanSouth Korea2
Soonchunhyang University HospitalBucheon-siSouth Korea2
Soonchunhyang University HospitalSeoulSouth Korea3
Wonju Severance Christian HospitalWŏnjuSouth Korea16
Yongin Severance HospitalYonginSouth Korea7